| This week's sponsor is Biotech Primer. | | | |
| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Tuesday, August 28, 2018 Genentech is handing over $96 million (€82 million) in upfront and near-term payments to work with Affimed on NK and T-cell engagers. The deal features $5 billion in milestones and royalties that could land in Affimed’s bank account if the immunotherapies succeed. |
|
|
Top Stories Of The Week Friday, August 24, 2018 Shire’s got a brand-new approval on its hands that could help it dominate the hereditary angioedema market for years to come—and rack up blockbuster sales in the process. Wednesday, August 29, 2018 Locked in a legal fight—and biosimilars marketing battles—Pfizer used an FDA petition to lambaste Johnson & Johnson, Amgen and Genentech for what it called "false and misleading" information about copycat biologics. Wednesday, August 29, 2018 The biotech boom is having a big effect on the pay packets of equity analysts, according to The Wall Street Journal. Driven by a desire to show they understand biotech, banks are reportedly paying analysts up to $4 million a year, several times more than the typical salary in other industries. Monday, August 27, 2018 What a comedown for Johnson & Johnson's Xarelto at the European Society of Cardiology annual meeting. Last year, J&J touted data that put the clot-buster on track for a new $1 billion-plus approval. This time, the company was forced to admit Xarelto had flopped—and not once, but twice. Monday, August 27, 2018 Scientists at the Allen Institute for Brain Science discovered a brain cell that’s found in humans but not in mice. They believe scrutinizing this newly discovered neuron could help guide efforts toward treatments for neurological diseases. Tuesday, August 28, 2018 The leader of Roche’s diagnostics division, Roland Diggelmann, announced plans to leave the company, effective Sept. 30. Roche Diagnostics accounted for nearly a quarter of the Swiss giant's sales, growing 5% in 2017 to bring in about $12.4 billion. Tuesday, August 28, 2018 A packaging issue for a children's pain medication is confounding parents and has led to Pfizer recalling a Children’s Advil product it says could result in overdoses. Tuesday, August 28, 2018 CDC officials have been pushing HPV vaccination, and in 2017—just as in the previous four years—those efforts yielded only a slight increase. About half of U.S. adolescents have been fully vaccinated against the cancer-causing virus, far short of the 80% officials are aiming for by 2020. Monday, August 27, 2018 Chinese contract R&D and manufacturing giant WuXi AppTec promoted Edward Hu from CFO to co-CEO. He will continue to report to Ge Li, chairman and chief executive. Resources Sponsored by: AWS and Tableau Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children. Sponsored by: AWS and Reltio Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS. Presented by: AWS and Druva Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data. Sponsored by: Health Strategies Group The window of market exclusivity continues to narrow dramatically in the global marketplace. Given this demanding environment, your global market access team faces increasing urgency to get the value proposition right at the time of launch. Sponsored by: WCG Selecting the right sites is the most crucial decision you’ll make in your next clinical trial, and the single most important factor to consider in selecting a site is whether or not it can meet its enrollment goals. Sponsored by: Veeva Industry Research: See new results from one of the industry's largest, global clinical operations surveys. Sponsored by: Veeva Ready to modernize your RIM environment? Secure buy-in with these tips. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. |
